Literature DB >> 10920086

Impact of oestradiol and inhibin A concentrations on pregnancy rate in in-vitro oocyte maturation.

A L Mikkelsen1, S Smith, S Lindenberg.   

Abstract

The purpose of the present study was to analyse the results of maturation of oocytes obtained in unstimulated normal women after a leading follicle of 10 mm diameter and an endometrium of at least 5 mm thickness were observed at ultrasound. The serum concentrations of oestradiol and inhibin A were analysed from day 3 to the day of aspiration and retrospectively evaluated. A total of 75 normal regular cycling women referred for IVF/intracytoplasmic sperm injection (ICSI) because of male factor and/or tubal disease was included (n = 87 consecutive cycles). The oocytes were aspirated transvaginally and matured for 28-36 h. ICSI was performed on all metaphase II oocytes and they were cultured to day 2 or 3 after insemination, at which time suitable embryos (maximum two) were replaced into the women. Eleven singleton pregnancies with a live fetus were obtained after transfer in 63 cycles (pregnancy rate of 13% per aspiration and 17% per transfer). Nine healthy children have been born and the remaining two pregnancies miscarried in the eighth to ninth gestational week. The serum concentrations of oestradiol on day 3 and on the day of aspiration were available in 85 cycles, and in 57 of these an increase of 100% was detected on the day of aspiration. Significantly more pregnancies were observed in these cycles compared with cycles without an increase in the concentration of oestradiol (19 versus 0% per aspiration, 24 versus 0% per transfer, P < 0.02). Further improvement in pregnancy rate was obtained if aspiration was performed after increase in inhibin A concentration (24 versus 0% per aspiration and 33 versus 0% per transfer, P < 0.02) (n = 83 cycles, where inhibin concentrations were available, and n = 42 cycles, where an increase of 80% was detected on the day of aspiration compared with day 3). Timing of aspiration may improve the developmental potential of immature oocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10920086     DOI: 10.1093/humrep/15.8.1685

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  Correlation between human follicular diameter and oocyte outcomes in an ICSI program.

Authors:  Anusorn Triwitayakorn; Somchai Suwajanakorn; Kamthorn Pruksananonda; Wisan Sereepapong; Vichuda Ahnonkitpanit
Journal:  J Assist Reprod Genet       Date:  2003-04       Impact factor: 3.412

2.  Endometrial preparation for in vitro oocyte maturation: early use of estrogen increases endometrial tissue and requires lower daily dosage: a cross over trial in 'mock' cycles.

Authors:  Wellington de Paula Martins; Rosana Maria dos Reis; Rui Alberto Ferriani; Carlos Henrique Medeiros de Araújo; Carolina Oliveira Nastri; Francisco Mauad Filho
Journal:  J Assist Reprod Genet       Date:  2006-05-19       Impact factor: 3.412

3.  Estradiol, progesterone, testosterone profiles in human follicular fluid and cultured granulosa cells from luteinized pre-ovulatory follicles.

Authors:  Xuesong Wen; Dong Li; Amanda J Tozer; Suzanne M Docherty; Ray K Iles
Journal:  Reprod Biol Endocrinol       Date:  2010-10-11       Impact factor: 5.211

4.  Follicular steroid hormones as markers of oocyte quality and oocyte development potential.

Authors:  Nayara López Carpintero; Onica Armijo Suárez; Carmen Cuadrado Mangas; Carolina González Varea; Rubén Gómez Rioja
Journal:  J Hum Reprod Sci       Date:  2014-07

5.  The in vitro effect of chick embryo extract on mice pre-antral follicles.

Authors:  Hossein Torkashvand; Rouhollah Fathi; Abdolhossein Shahverdi; Afsaneh Golkar; Paul Edward Mozdziak; Hussein Eimani
Journal:  Vet Res Forum       Date:  2019-09-15       Impact factor: 1.054

Review 6.  Factors Influencing the In Vitro Maturation (IVM) of Human Oocyte.

Authors:  Huixia Yang; Thomas Kolben; Sarah Meister; Corinna Paul; Julia van Dorp; Sibel Eren; Christina Kuhn; Martina Rahmeh; Sven Mahner; Udo Jeschke; Viktoria von Schönfeldt
Journal:  Biomedicines       Date:  2021-12-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.